This was a long time ago, 2017.
And this was still being said at the end of 2019 —that was due to when the US manufacturing predominant financial arm of Lederle, got acquired, and a “rolling series of mergers “ subsequently occurred.
‘Bisantrene lost’ in amongst all.
Lederle really had been French only in name since 1929 in America, when US interests predominantly acquired the company but kept Lederle name also.
There was a significant portfolio of drugs but esp antibiotics etc maybe wanted, and the famed facilities. (can google Lederle and they really were very respected for nearly 100 years)
Peter Molloy , 2017 -
https://youtu.be/ObLlKrCUyDQ?si=TxVrERAffDng_KP6
&
https://www.abc.net.au/news/2017-08-31/betadine-gargle-creator-peter-molloy-eyes-discarded-cancer-drugs/8857556
- Forums
- ASX - By Stock
- Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
This was a long time ago, 2017. And this was still being said at...
-
- There are more pages in this discussion • 354 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.63 |
Change
-0.035(2.11%) |
Mkt cap ! $278.6M |
Open | High | Low | Value | Volume |
$1.68 | $1.68 | $1.61 | $91.17K | 56.05K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4572 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.64 | 804 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4572 | 1.625 |
2 | 7543 | 1.620 |
2 | 30930 | 1.615 |
2 | 16249 | 1.610 |
3 | 24875 | 1.600 |
Price($) | Vol. | No. |
---|---|---|
1.635 | 804 | 2 |
1.640 | 2577 | 1 |
1.645 | 5264 | 1 |
1.650 | 1975 | 1 |
1.665 | 845 | 1 |
Last trade - 12.21pm 06/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |